Entry
Reader's guide
Entries A-Z
Subject index
Lysergic acid diethylamide (LSD) is manufactured from lysergic acid, a substance derived from ergot fungus, which grows on rye and other grains or acid amide. LSD is most commonly taken orally in tablet or capsule form, or ingested on blotter paper. The effects of the drug occur 30 to 90 minutes after ingestion. Common effects include auditory or visual hallucinations, a general feeling of well-being, connection with a “higher power,” or a combination thereof. Synesthesia, a state where one believes he or she is able to taste colors or see sounds, may also occur. At a low dose, LSD is a stimulant.
Other effects of LSD include: dilated pupils, higher body temperature, increased heart rate and blood pressure, loss of appetite, sleeplessness, dry mouth, tremors, numbness, weakness, and nausea. LSD has many street names, including acid, blotter, cid, doses, and trips. Although LSD has a low incidence of abuse, individuals under the influence of LSD may demonstrate weak or unsound judgment, which can lead to fatal accidents. This particular effect has been utilized by governments to regulate manufacturing, distribution, and potential research with LSD. Like heroin and marijuana, LSD is classified as a Schedule I drug in the Controlled Substance Act.
LSD has an interesting history that transcends its discovery and the various policies developed to regulate its use over time. LSD was a cornerstone of the counterculture movement of the 1960s, in which individuals were encouraged to “turn on, tune in, and drop out.”
Discovery and Early Uses
LSD was discovered by accident by Albert Hofmann, who first synthesized it in 1938. That year, Hofmann's intended research program was to discover ergot alkaloid derivatives for medicinal use. Hofmann did not know that the synthesis of ergot, a grain fungus that grows on rye, had psychotropic properties. After a five-year pause in this research, Hofmann again began synthesizing LSD. In 1943 he inadvertently discovered the psychotropic powers of the drug. Initially, Hofmann was unsure as to how his sensations of dizziness and visual hallucinations occurred. Upon reflecting he hypothesized that during his work a quantity of LSD had been either absorbed through the skin on his fingertips or ingested in some other way.
Hofmann was interested in the powerful and mind-altering properties of LSD and initiated a series of self-experiments under the watchful eye of his lab assistant. The greater the dosage, Hofmann discovered, the more intense the hallucinations. After this self experimentation, Hofmann notified the board of directors at the Sandoz lab and testing of LSD soon commenced under the supervision of the psychiatrist W. A. Stoll. Within five years, Sandoz Laboratories had distributed LSD in the United States and United Kingdom for use in psychotherapy. Sandoz Laboratories did not, however, engage in a formal marketing campaign for LSD. Sandoz discontinued the manufacturing of LSD in 1965 due to public and political pressure.
Therapeutic Uses
From the 1940s through the early 1960s LSD was administered in controlled environments, often in conjunction with talk therapy. The use of LSD as a part of therapy was serendipitous. LSD and other hallucinogens supported Freudian and Jungian therapeutic protocols that emphasized the role of the unconscious in the development of the healthy individual. Research from the late 1940s through the 1960s supported the notion that the effects of LSD could expedite therapy in individuals with challenging diagnoses, such as addictions, character disorders, sexual deviations, and terminal illness. With the first three problems, LSD was potentially helpful to the patient due to the principle reactions from the drug's administration: hallucinations, a feeling of well-being, spiritual transcendence, and synesthesia. These effects were used as a catalyst in assisting the patient in confronting and working through his or her repressed thoughts and experiences existing within his or her unconscious.
...
- Employment Division v. Smith (1990)
- Gonzales v. O Centro Espirita Beneficente União do Vegetal (2006)
- Gonzales v. Oregon
- Gonzales v. Raich (2005)
- Gore v. United States (1958)
- Indianapolis v. Edmond (2000)
- Jin Fuey Moy v. United States (1920)
- Leary v. United States (1967)
- Lewis v. United States (1966)
- Linder v. United States (1925)
- People v. Woody (1964)
- United States v. Doremus (1919)
- United States v. Jeffers (1951)
- United States v. Kuch (1968)
- United States v. Sanchez (1950)
- United States v. Warner (1984)
- Convention on Psychotropic Substances, 1971
- Narcotics Limitation Convention of 1931
- National Commission on Marijuana and Drug Abuse (1972)
- 1909 Shanghai Conference
- 1912 Hague Conference
- 1925 Geneva Convention on Opium and Other Drugs
- 1946 Revision of the Harrison Act
- Single Convention on Narcotic Drugs, 1961
- United Nations Convention Against the Illicit Traffic in Narcotic Drugs
- Afghanistan
- Algeria
- Argentina
- Australia
- Azerbaijan
- Bahamas
- Bangladesh
- Belarus
- Belize
- Benin
- Bolivia
- Brazil
- Cambodia
- Canada
- Chile
- China
- Colombia
- Congo
- Costa Rica
- Cuba
- Denmark
- Dominican Republic
- Ecuador
- Egypt
- El Salvador
- France
- Germany
- Ghana
- Greece
- Guatemala
- Haiti
- Honduras
- Hong Kong
- India
- Indonesia
- Iran
- Iraq
- Ireland
- Israel
- Italy
- Jamaica
- Japan
- Jordan
- Kazakhstan
- Kenya
- Korea, South
- Kyrgyzstan
- Lao PDR
- Lebanon
- Libya
- Malaysia
- Mexico
- Morocco
- Myanmar
- Netherlands
- New Zealand
- Nicaragua
- Nigeria
- Pakistan
- Panama
- Papua New Guinea
- Paraguay
- Peru
- Philippines
- Poland
- Portugal
- Romania
- Russia
- Saudi Arabia
- Senegal
- Singapore
- South Africa
- Spain
- Sweden
- Switzerland
- Tajikistan
- Thailand
- Tunisia
- Turkey
- Uganda
- Ukraine
- United Kingdom
- United States
- Uruguay
- Uzbekistan
- Venezuela
- Vietnam
- Yemen
- Anti-Drug Operations, Pre-1960s
- Anti-Drug Operations, 1960s
- Anti-Drug Operations, 1970s
- Anti-Drug Operations, 1980s
- Anti-Drug Operations, 1990s
- Anti-Drug Operations, 2000s
- Asset Forfeiture
- Cocaine Cartels
- Data Collection Systems
- Drug Trafficking and Political Movements
- Drugs and Money Laundering
- Drugs and Terrorism
- Drugs-Crime Connection
- Golden Crescent
- Golden Triangle
- Prices and Volumes in Illicit Markets, Theories of
- Set and Setting
- Alabama Laws and Programs
- Alaska Laws and Programs
- Alcohol and Drug Abuse Education Amendments (1978)
- Analogue (Designer Drug) Act
- Anti-Drug Abuse Act (Drug-Free America Act)
- Anti-Drug Abuse Amendment Act
- Anti-Drug War Movement
- Arizona Laws and Programs
- Arkansas Laws and Programs
- Aviation Drug-Trafficking Control Act
- Boggs Act
- California Laws and Programs
- Colorado Laws and Programs
- Community Mental Health Centers Act
- Comprehensive Crime Control Act of 1984
- Comprehensive Drug Abuse Prevention and Control Act
- Comprehensive Methamphetamine Control Act
- Connecticut Laws and Programs
- Controlled Substance Registrant Protection Act
- Controlled Substances Import and Export Act
- Controlled Substances Penalties Amendments Act
- Criminal Justice/Enforcement Strategies of Drug Control
- Dangerous Drug Diversion Control Act
- Delaware Laws and Programs
- Demand-Side Policies
- Diversion Programs
- Drug Abuse Control Amendments (1965)
- Drug Courts
- Drug Policies: General Strategies
- Drug Policy Effects on Rates of Crime
- Drug Policy Effects on Rates of Drug-Related Illnesses
- Drug Policy Effects on Rates of Drug-Related Injuries
- Drug Policy Effects on Rates of Incarceration
- Drug Policy Effects on Rates of Use
- Drug-Free Communities Act
- Drugs and the Death Sentence
- Durham-Humphrey Act
- Ecstasy Anti-Proliferation Act
- Eighteenth Amendment to the U.S. Constitution
- Elite Model of Drug Laws
- Elite-Engineered Moral Panics
- Florida Laws and Programs
- Food and Drug Administration
- Georgia Laws and Programs
- Grassroots Model of Drug Laws
- Grassroots Moral Panics
- Group Model of Drug Laws
- Harrison Act
- Hawaii Laws and Programs
- Heroin Trafficking Act
- Idaho Laws and Programs
- Illicit Drug Anti-Proliferation Act
- Illinois Laws and Programs
- Indiana Laws and Programs
- International Drug Policies: Eradication of Narcotic Crops
- International Drug Policies: Interdiction and Law Enforcement
- International Drug Policies: International Cooperation
- International Drug Policies: Sanctions/Economic Assistance
- Iowa Laws and Programs
- “Just Say No”
- Kansas Laws and Programs
- Kentucky Laws and Programs
- Louisiana Laws and Programs
- Maine Laws and Programs
- Mandatory Sentencing
- Marihuana Tax Act (1937)
- Maryland Laws and Programs
- Massachusetts Laws and Programs
- Methadone Control Act
- Michigan Laws and Programs
- Minnesota Laws and Programs
- Mississippi Laws and Programs
- Missouri Laws and Programs
- Montana Laws and Programs
- Moral Panics and Drug Laws
- Narcotic Addict Rehabilitation Act
- Narcotic Control Act
- Narcotic Drug Act
- Narcotic Drug Import and Export Act
- Narcotics Manufacturers Act
- National Narcotics Act
- Native Races Act
- Nebraska Laws and Programs
- Nevada Laws and Programs
- New Hampshire Laws and Programs
- New Jersey Laws and Programs
- New Mexico Laws and Programs
- New York Laws and Programs
- 1946 Revision of Harrison Act
- North Carolina Laws and Programs
- North Dakota Laws and Programs
- Office of National Drug Control Policy Reauthorization Act
- Ohio Laws and Programs
- Oklahoma Laws and Programs
- Omnibus Drug Abuse Act
- Opium Poppy Control Act
- Oregon Laws and Programs
- Pennsylvania Laws and Programs
- Policies Regulating Alcohol, U.S.
- Policies Regulating Pharmaceutical Drugs, U.S.
- Policies Regulating Tobacco, U.S.
- Policing Techniques in the War on Drugs
- Porter Narcotic Farm Act
- Pure Food and Drug Act
- Reducing Americans' Vulnerability to Ecstasy Act (RAVE Act)
- Religious Freedom and Drug Laws
- Rhode Island Laws and Programs
- Rockefeller Laws
- Schedule of Controlled Substances
- South Carolina Laws and Programs
- South Dakota Laws and Programs
- Supply-Side Policies
- Tennessee Laws and Programs
- Testing and Sanctions
- Texas Laws and Programs
- Twenty-First Amendment to the U.S. Constitution
- Uniform State Narcotics Act
- Utah Laws and Programs
- Vermont Laws and Programs
- Virginia Laws and Programs
- Volstead Act
- “War on Drugs”
- Washington Laws and Programs
- Webb-Kenyon Act
- West Virginia Laws and Programs
- Wisconsin Laws and Programs
- Workplace: Drug-Free Policy
- Workplace: Role, Prevention, and Programs
- Wyoming Laws and Programs
- Zero Tolerance
- Alcoholics Anonymous
- Anti-Drug Grassroots Organizations
- Anti-Tobacco Campaigns
- Armed Forces
- Bureau of Drug Abuse Control
- Bureau of Narcotics and Dangerous Drugs
- D.A.R.E.
- Drug Enforcement Administration
- Drug Treatment Programs
- Federal Bureau of Narcotics
- International Drug Agencies
- International Narcotics Control Board
- Narcotics Anonymous
- National Organization for Reform of Marijuana Laws
- Office of Drug Abuse Law Enforcement
- Office of National Drug Control Policy
- Office of National Narcotics Intelligence
- Partnership for a Drug-Free America
- President's Advisory Commission on Narcotics and Drug Abuse (Prettyman)
- Secular Organizations for Sobriety
- Social Movements Against Drunken Driving
- Temperance Movement
- United Nations Office on Drugs and Crime
- U.S. Department of State Bureau of International Narcotics and Law Enforcement Affairs
- Women for Sobriety
- Ambrose, Myles
- Anslinger, Harry
- Bartels, John
- Bennett, William
- Bensinger, Peter
- Bonner, Robert
- Bourne, Peter
- Brown, Lee
- Constantine, Thomas
- Dupont, Robert
- Giordano, Henry
- Greene, Stephen
- Hutchinson, Asa
- Ingersoll, John
- Kerlikowske, Gil
- Lawn, John
- Leonhart, Michele
- Lindesmith, Alfred
- Marshall, Donnie
- Martinez, Bob
- McCaffrey, Barry R.
- Mill, John Stuart
- Mullen, Francis
- Sullivan, William
- Tandy, Karen
- Turner, Carlton
- Walters, John
- Bush Administration, George H. W.
- Bush Administration, George W.
- Carter Administration, James
- Clinton Administration, William
- Coolidge Administration, Calvin
- Eisenhower Administration, Dwight
- Ford Administration, Gerald
- Harding Administration, Warren
- Hoover Administration, Herbert
- Johnson Administration, Lyndon
- Kennedy Administration, John F.
- Nixon Administration, Richard
- Obama Administration, Barack
- Presidential Administrations Prior to Federal Drug Regulation
- Reagan Administration, Ronald
- Roosevelt Administration, Franklin D.
- Roosevelt Administration, Theodore
- Taft Administration, William Howard
- Truman Administration, Harry
- Wilson Administration, Woodrow
- Addiction Maintenance
- Coerced Drug Treatment
- Disease Model of Use
- Drug Abuse Warning Network
- Drug Testing
- Drug Treatment Programs
- Evaluative Evidence of Prevention Programs
- Evaluative Evidence of Rehab/Treatment Programs
- Group Therapy
- Harm Reduction
- Inpatient Treatment Programs
- Laboratory Techniques
- Needle Exchange Programs
- Prescription Drug Abuse
- Prevention Programs
- Rational Addiction Model of Drug Use
- Rehabilitation/Treatment Programs
- Safe Injection Rooms
- Single Distribution Theory of Consumption
- SMART Recovery
- 12-Step Recovery Programs
- Alcohol
- Amphetamines
- Antagonist Medications
- Barbiturates
- Caffeine
- Club Drugs
- Cocaine
- Crack
- Ecstasy
- Freebase
- Hallucinogens
- Heroin
- Inhalants
- Ketamine
- Khat
- LSD
- Marijuana
- Methadone
- Methamphetamine
- Morphine
- Over-the-Counter Drugs
- Salvia Divinorum
- Sedatives
- Steroids
- Synthetic Narcotics
- Tobacco
- Loading...
Get a 30 day FREE TRIAL
-
Watch videos from a variety of sources bringing classroom topics to life
-
Read modern, diverse business cases
-
Explore hundreds of books and reference titles
Sage Recommends
We found other relevant content for you on other Sage platforms.
Have you created a personal profile? Login or create a profile so that you can save clips, playlists and searches